ライフサイエンスコーパス: mesenchymal stem cell

1 lood vessels generated by DPSCs (a model for mesenchymal stem cells).

2 in both mouse 3T3-L1 preadipocytes and mouse mesenchymal stem cells.

3 fication of adipose- and bone marrow-derived mesenchymal stem cells.

4 om multiple progenitor cell types, including mesenchymal stem cells.

5 to enhanced biomolecule delivery into human mesenchymal stem cells.

6 ated that pASCs exhibited characteristics of mesenchymal stem cells.

7 last differentiation and bone formation from mesenchymal stem cells.

8 processes involving mural cells and derived mesenchymal stem cells.

9 s such as dermal fibroblasts and endometrial mesenchymal stem cells.

10 outperform bone marrow-mononuclear cells and mesenchymal stem cells.

11 to adhered cells was demonstrated with human mesenchymal stem cells.

12 PCR in human synovial fibroblasts and murine mesenchymal stem cells.

13 define populations of incisor epithelial and mesenchymal stem cells.

14 interactions during differentiation of human mesenchymal stem cells.

15 ression in differentiating human bone marrow mesenchymal stem cells.

16 erial-induced phenotypical response of human mesenchymal stem cells.

17 ates 25-hydroxyvitamin D(3) actions in human mesenchymal stem cells.

18 eage selection of their common progenitors - mesenchymal stem cells.

19 intraperitoneal injection of human amniotic mesenchymal stem cells (AFSCs) into a mouse model of OI

20 heir transformations upon internalization in mesenchymal stem cells and as a function of the cells' d

21 The mutation occurs in differentiating mesenchymal stem cells and associates with an impaired o

22 ypes of bone marrow mononuclear cells: CD90+ mesenchymal stem cells and CD45+ CD14+ auto-fluorescent+

23 CAFs), epithelial to mesenchymal transition, mesenchymal stem cells and expressed high levels of coll

24 oned media (TCM) on gene expression in human mesenchymal stem cells and fibroblasts.

25 s and the recruitment of bone marrow-derived mesenchymal stem cells and fibrocytes.

26 ctivity in primary human bone marrow-derived mesenchymal stem cells and human osteosarcoma-derived ce

27 rentiation in vitro and expressed markers of mesenchymal stem cells and macrophages, which may potent

28 me of individual xenogeneic hybrids of human mesenchymal stem cells and murine cardiomyocytes soon af

29 was significantly reduced in senescent human mesenchymal stem cells and myofibroblasts derived from p

30 The viability of human mesenchymal stem cells and osteoblastic SaOS-2 cells was

31 enotypes resembling foam cells, macrophages, mesenchymal stem cells and osteochondrogenic cells, whic

32 Furthermore, Fbw7-depleted human mesenchymal stem cells and primary mouse calvarial cells

33 review directions and advances in the use of mesenchymal stem cells and their derived hepatocytes for

34 of primary cells such as haematopoietic and mesenchymal stem cells and, more recently, derivatives o

35 ll populations, such as neuronal precursors, mesenchymal stem cells, and preadipocytes, where it regu

36 Similar findings were obtained with human mesenchymal stem cells, and results were confirmed by ta

37 ineage commitment of primary mouse and human mesenchymal stem cells, and support the growth of a broa

38 of therapeutic agents include vasodilators, mesenchymal stem cells, antiinflammatory agents, antiinf

39 hase 1 trial to determine whether autologous mesenchymal stem cells, applied in a bioabsorbable matri

40 Flowthrough c-Kit(-) mesenchymal stem cells are positively selected by surfac

41 ls (BMSCs, also known as bone marrow-derived mesenchymal stem cells) are manufactured using many diff

42 nsic skeletal stem cells (SSCs), a subset of mesenchymal stem cells, are essential for resolution of

43 ared to HEK 293 normal cells and bone marrow mesenchymal stem cells (BM-hMSCs).

44 found that BP180 is expressed by bone marrow mesenchymal stem cells (BM-MSC), and its functional defi

45 morphological changes of bone marrow-derived mesenchymal stem cells (BM-MSC), and Michigan Cancer Fou

46 s a valid alternative to bone marrow-derived mesenchymal stem cells (BMMSC) for cartilage repair stra

47 Bone marrow-derived mesenchymal stem cells (BMSCs) have the potential of rep

48 Bone mesenchymal stem cells (BMSCs) on the 3D nanofiber assem

49 ce has demonstrated that bone marrow-derived mesenchymal stem cells (BMSCs) showed great potential in

50 modeling, the differentiation of bone marrow mesenchymal stem cells (BMSCs) to osteoblasts and chondr

51 eous iron overload clearance and bone marrow mesenchymal stem cells (BMSCs) transplantation following

52 lates were cultured with bone marrow derived mesenchymal stem cells (BMSCs) using the in vitro direct

53 ve target cells, such as bone marrow-derived mesenchymal stem cells (BMSCs), remains challenging.

54 ly alter the enhancer chromatin landscape of mesenchymal stem cells by impeding methylation at lysine

55 Ovarian carcinoma-associated mesenchymal stem cells (CA-MSC) produce not only high le

56 tor cells, endothelial progenitor cells, and mesenchymal stem cells can be successfully concurrently

57 We found placement of mesenchymal stem cell-coated matrix fistula plugs in 12

58 ting of mature white adipocytes, multipotent mesenchymal stem cells, committed progenitor cells, fibr

59 We evaluated the therapeutic potential of mesenchymal stem cell-conditioned medium (CM-MSC) as an

60 Conversely, Egr1 overexpression in mesenchymal stem cells decreases beige adipocyte differe

61 not been well characterized and compared in mesenchymal stem cells derived from human dental pulp (D

62 tential biomarkers for potency prediction of mesenchymal stem cell-derived and pluripotent stem cell-

63 Mesenchymal stem cell-derived extracellular vesicles (MS

64 Bone marrow mesenchymal stem cell-derived extracellular vesicles (MS

65 lance between bone formation, carried out by mesenchymal stem cell-derived osteoblasts, and bone reso

66 Mesenchymal stem cells differentiate into distinct mesen

67 in vitro, compared with bone marrow-derived mesenchymal stem cells, displayed a 55-fold increase in

68 emodeling of the nuclear morphology of human mesenchymal stem cells during biochemically-induced adip

69 reveals the temporal gene signature of human mesenchymal stem cells during chondrogenesis.

70 ective microenvironment for chondrocytes and mesenchymal stem cells during inflammation and regenerat

71 tissue-engineered cultures comprised of rat mesenchymal stem cells dynamically seeded on 85% porous

72 ring adipogenic differentiation in mouse ear mesenchymal stem cells (eMSCs) and the murine preadipocy

73 also was up-regulated in cultured murine ear mesenchymal stem cells (EMSCs) during adipogenesis.

74 lly or physiologically related cells, namely mesenchymal stem cells, endothelial cells or granulocyte

75 , VEGF produced by mixed retinal cells or by mesenchymal stem cells exerted a paracrine neuroprotecti

76 Interestingly, human mesenchymal stem cells exposed in vitro to medium condit

77 sterix is a critical transcription factor of mesenchymal stem cell fate, where its loss or loss of Wn

78 ENT3 deficiency alters hematopoietic and mesenchymal stem cell fates; the former leads to stem ce

79 Notable examples include mesenchymal stem cells for tissue regeneration, islet tr

80 We here test whether a new population of mesenchymal stem cells from human gingiva (GMSCs), which

81 t creation of 4 clones using adipose-derived mesenchymal stem cells from Snuppy as donor cells.

82 cord derived ECM hydrogels can deliver human mesenchymal stem cells from the apical papilla (SCAP) to

83 human somatic cells of different phenotypes: mesenchymal stem cells from the limbal eye stroma and ep

84 dons differentiated from bone marrow derived mesenchymal stem cells from young (20-24 years) and old

85 Here, we show that glioma-associated human mesenchymal stem cells (GA-hMSC), a newly identified str

86 r vesicles (EVs) released by gingiva-derived mesenchymal stem cells (GMSC-EVs) on oxidative stress-in

87 extracellular matrix (SIS-ECM) with gingival mesenchymal stem cells (GMSCs) or their derivative exoso

88 esenchymal stem cells (PDLMSCs) and gingival mesenchymal stem cells (GMSCs).

89 ems were seen to be ideal for the support of mesenchymal stem cell growth, as shrinkage of fibers nor

90 d repair to allow for the selection of human mesenchymal stem cells harboring the oncogenic transloca

91 Trained murine mesenchymal stem cells have anti-inflammatory effect on

92 Although bone marrow-derived mesenchymal stem cells have been previously assessed for

93 ajor factor VIII (FVIII) synthesis site, and mesenchymal stem cells have been shown to control joint

94 LI by injection of human bone marrow derived mesenchymal stem cells (hBD-MSCs) with or without solubl

95 Human limbus-derived stromal/mesenchymal stem cells (hLMSC) can be one of the alterna

96 s been described to differently affect human mesenchymal stem cell (hMSC) and mouse mesenchymal stem

97 rs have demonstrated that PEDF directs human mesenchymal stem cell (hMSC) commitment to the osteoblas

98 the physiological role of succinate on human mesenchymal stem cell (hMSC) migration by regulating the

99 Promoting the paracrine effects of human mesenchymal stem cell (hMSC) therapy may contribute to i

100 Human mesenchymal stem cell (hMSC) transplantation therapy is

101 ing, in maintaining a younger state of human mesenchymal stem cells (hMSCs) and ameliorating osteoart

102 ty in both the nematode C. elegans and human mesenchymal stem cells (hMSCs) by disrupting the SKN-1/N

103 elease/recovery of 3T3 fibroblasts and human mesenchymal stem cells (hMSCs) from 3D cultures while ma

104 Although human mesenchymal stem cells (hMSCs) have been tested in ische

105 o manipulate nuclear mechanosensing in human mesenchymal stem cells (hMSCs) in vitro.

106 (DR8(dex2)) accelerated senescence in human mesenchymal stem cells (hMSCs) independent of its microR

107 during the in vitro differentiation of human mesenchymal stem cells (hMSCs) into chondrocytes.

108 RATIONALE: Myocardial delivery of human mesenchymal stem cells (hMSCs) is an emerging therapy fo

109 Cartilage grown from human mesenchymal stem cells (hMSCs) is poorly organized and u

110 Osteoblast differentiation of human mesenchymal stem cells (hMSCs) is stimulated by 1alpha,2

111 ructs seeded with porcine AF cells and human mesenchymal stem cells (hMSCs) showed approximately 2.2-

112 otypic response of human bone marrow-derived mesenchymal stem cells (hMSCs) to 2176 randomly generate

113 the time-dependent response of primary human mesenchymal stem cells (hMSCs) to cyclic tensile strain

114 ative functions of human bone marrow-derived mesenchymal stem cells (hMSCs) transplanted in murine bo

115 potential of adipose tissue - derived human mesenchymal stem cells (hMSCs) was evaluated in vitro.

116 protein corona on stem cell labeling, human mesenchymal stem cells (hMSCs) were labeled with the abo

117 from pre-osteoblastic MC3T3 cells and human mesenchymal stem cells (hMSCs).

118 MRI, with bone marrow-derived primary human mesenchymal stem cells (hMSCs).

119 OH)D3 on osteogenic differentiation of human mesenchymal stem cells (hMSCs).

120 suggest that mutations in Evc2 affect dental mesenchymal stem cell homeostasis, which further leads t

121 c stem cell sheet using human umbilical cord mesenchymal stem cells (hUC-MSC) that present low antige

122 Human umbilical cord mesenchymal stem cells (hUC-MSCs), originating in Wharto

123 oses of allogeneic bone marrow-derived human mesenchymal stem cells identically delivered in patients

124 Importantly, unlike mesenchymal stem cells, iMS cells contribute directly to

125 ion in the synovial fibroblasts or in murine mesenchymal stem cells in a dose- and time-dependent man

126 tion, mediated by a limited number of dental mesenchymal stem cells in Evc2 mutant mice.

127 enefits than their counterparts derived from mesenchymal stem cells in some measures.

128 induced the differentiation of encapsulated mesenchymal stem cells in vitro.

129 Actually, pulp mesenchymal stem cells, including postnatal dental pulp

130 Adult mesenchymal stem cells, including preadipocytes, possess

131 ges in conventional cell culture systems and mesenchymal stem cells inside biomimetic hydrogels that

132 ve been implicated in the differentiation of mesenchymal stem cells into various cell lineages.

133 Neural differentiation of mesenchymal stem cells is a controversial phenomenon, as

134 x-forming system where the membrane of human mesenchymal stem cells is modified to display a novel th

135 vation of FFA4 expressed by murine C3H10T1/2 mesenchymal stem cells is required for induced different

136 latin methacryloyl hydrogel laden with human mesenchymal stem cells, is used to locally stimulate ost

137 ogenic marker genes in mouse osteoblasts and mesenchymal stem cell-like cells.

138 ified its downstream target as stromal GLI1+ mesenchymal stem cell-like cells.

139 lar smooth muscle cells (VSMCs) derived from mesenchymal stem cell-like progenitors.

140 ofibroblast differentiation of lung resident mesenchymal stem cells (LR-MSCs) and in the lung tissues

141 nerating cells that had a high percentage of mesenchymal stem cell markers CD29, CD44, CD146 and Stro

142 showed a perivascular co-localization of the mesenchymal stem cell markers STRO1 and C5L2.

143 their number by symmetric division, express mesenchymal stem cell markers, and generate chondrocytes

144 so expressed a similar phenotypic profile of mesenchymal stem cell markers, except a relatively highe

145 and Msx2 genes in mouse bone marrow-derived mesenchymal stem cells (mBMSCs) to regenerate a proximal

146 human mesenchymal stem cell (hMSC) and mouse mesenchymal stem cell (mMSC) immunomodulation and differ

147 ginally named RNF144A-AS1) as a regulator of mesenchymal stem cell (MSC) chondrogenesis.

148 oblasts (MO-EVs) to induce mineralisation in mesenchymal stem cell (MSC) cultures and delineate the u

149 Human mesenchymal stem cell (MSC) extracellular vesicles (EV)

150 g maintains tissue homeostasis and regulates mesenchymal stem cell (MSC) fate by mediating WNT and FG

151 time, we determined that a circRNA controls mesenchymal stem cell (MSC) identity and differentiation

152 of low intensity vibration (LIV), increases mesenchymal stem cell (MSC) osteogenesis and proliferati

153 We show that tropoelastin alone drives mesenchymal stem cell (MSC) proliferation and phenotypic

154 hesive capacity of the surfaces and instruct mesenchymal stem cell (MSC) response.

155 RATIONALE: Virtually all mesenchymal stem cell (MSC) studies assume that therapeu

156 Mesenchymal stem cell (MSC) therapies demonstrate partic

157 Mesenchymal stem cell (MSC) therapy has been shown to be

158 RATIONALE: Potential benefits of mesenchymal stem cell (MSC) therapy in heart failure may

159 The potential of a mesenchymal stem cell (MSC) therapy to accelerate the re

160 mulating data support a therapeutic role for mesenchymal stem cell (MSC) therapy; however, there is n

161 immense potential for neurovascularization, mesenchymal stem cell (MSC) transplantation has shown em

162 The mesenchymal stem cell (MSC), known to remodel in disease

163 Mesenchymal stem cell (MSC)-based therapy has shown grea

164 plicated diverse organ-resident perivascular mesenchymal stem cell (MSC)-like cells and bone marrow-M

165 mooth muscle cell (SMC) reprogramming into a mesenchymal stem cell (MSC)-like state.

166 Mesenchymal stem cell (MSC)-mediated immunomodulation af

167 Mesenchymal stem cells (MSC) are currently employed for

168 Mesenchymal stem cells (MSC) are promising therapeutics

169 ponse to chemical stimuli from cancer cells, mesenchymal stem cells (MSC) can differentiate into canc

170 response to musculoskeletal trauma, in which mesenchymal stem cells (MSC) differentiate into osteocho

171 Mesenchymal stem cells (MSC) exert antibacterial activit

172 Bone marrow-derived mesenchymal stem cells (MSC) have been promoted for mult

173 del of bronchopulmonary dysplasia (BPD) that mesenchymal stem cells (MSC) protect against hyperoxic l

174 owed human dermal fibroblast cells (HDF) and mesenchymal stem cells (MSC) to adhere, spread, and grow

175 ellar fat pad (IFP) serves as a reservoir of Mesenchymal Stem Cells (MSC), and with adjacent synovium

176 microenvironment, especially for bone marrow mesenchymal stem cells (MSC), in the maintenance and pro

177 res the generation of signals that stimulate mesenchymal stem cells (MSC), myofibroblasts and fibrobl

178 The mechanisms underlying mesenchymal stem cells' (MSC) suppressive potency are la

179 ed regenerative and antibacterial effects of mesenchymal stem cell (MSCs), we evaluated the safety an

180 tes suppresses fibrogenesis and desensitizes mesenchymal stem cells (MSCs) against subsequent mechani

181 to evaluate the neuroprotective potential of mesenchymal stem cells (MSCs) against the deleterious im

182 Mesenchymal stem cells (MSCs) ameliorate SLE symptoms by

183 We previously demonstrated that mesenchymal stem cells (MSCs) ameliorated experimental a

184 mitigate RIPF once it occurs, but recently, mesenchymal stem cells (MSCs) and a drug treatment stimu

185 entration on chondrogenesis of cocultures of mesenchymal stem cells (MSCs) and articular chondrocytes

186 The combination of autologous mesenchymal stem cells (MSCs) and cardiac stem cells (CS

187 ne the surface proteome of human bone marrow mesenchymal stem cells (MSCs) and human CPCs.

188 uman induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs) and human umbilical vein e

189 pproach involves real-time labeling of human mesenchymal stem cells (MSCs) and longitudinal tracking

190 bone marrow microenvironment (BMM), such as mesenchymal stem cells (MSCs) and macrophages, as well a

191 Here, mesenchymal stem cells (MSCs) and their nuclei spread in

192 Mouse BM progenitors and human mesenchymal stem cells (MSCs) appeared to contribute in

193 Although mesenchymal stem cells (MSCs) are a promising cell sourc

194 Mesenchymal stem cells (MSCs) are a promising therapeuti

195 Multipotent mesenchymal stem cells (MSCs) are important sources for

196 Mesenchymal stem cells (MSCs) are multipotent cells capa

197 ponse to tissue injury, both macrophages and mesenchymal stem cells (MSCs) are recruited to the site

198 Bone marrow derived mesenchymal stem cells (MSCs) are regularly utilized for

199 Mesenchymal stem cells (MSCs) are used extensively in de

200 Mesenchymal stem cells (MSCs) are widely considered to b

201 cartilage regeneration increasingly focus on mesenchymal stem cells (MSCs) as allogeneic cell sources

202 methylation changes during chondrogenesis of mesenchymal stem cells (MSCs) by Infinium 450 K methylat

203 Preclinical studies indicate that mesenchymal stem cells (MSCs) can stimulate angiogenesis

204 For mesenchymal stem cells (MSCs) cultured in three dimensio

205 study, we investigated the potential role of mesenchymal stem cells (MSCs) derived from human MT in t

206 Mesenchymal stem cells (MSCs) derived from periodontal l

207 Mesenchymal stem cells (MSCs) display a therapeutic plas

208 s secreted by human and mouse tumor-educated mesenchymal stem cells (MSCs) drive accelerated breast c

209 ring of plasma membrane viscosity changes in mesenchymal stem cells (MSCs) during osteogenic and chon

210 role of calcium (Ca(2+)) signaling in human mesenchymal stem cells (MSCs) during this process.

211 Adipose-derived (AD) mesenchymal stem cells (MSCs) especially have shown enco

212 Allogeneic mesenchymal stem cells (MSCs) exhibit immunoregulatory f

213 Human mesenchymal stem cells (MSCs) express scavenger receptor

214 Mesenchymal stem cells (MSCs) from PDL tissue were isola

215 ecently, nanoscale mechanical stimulation of mesenchymal stem cells (MSCs) has been shown to activate

216 unomodulatory effects of bone marrow derived mesenchymal stem cells (MSCs) has been widely studied an

217 Although antidepressant effects of mesenchymal stem cells (MSCs) have been reported, the po

218 Mesenchymal stem cells (MSCs) have multiple properties i

219 Mesenchymal stem cells (MSCs) have potential for reducin

220 In preclinical studies, mesenchymal stem cells (MSCs) have proven to be the most

221 chondrocytes (CHs) with bone marrow-derived mesenchymal stem cells (MSCs) improves their chondrogene

222 osed of endothelial cells (ECs) contact with mesenchymal stem cells (MSCs) in different tissues, sugg

223 the safety and efficacy of allogeneic human mesenchymal stem cells (MSCs) in reducing the time to re

224 Inconsistent therapeutic efficacy of mesenchymal stem cells (MSCs) in regenerative medicine h

225 n of two human cancer cell types and primary mesenchymal stem cells (MSCs) increases DNA breaks throu

226 icted migration of myoblastic cell types and mesenchymal stem cells (MSCs) increases nuclear rupture,

227 mmatory mediator-mediated communication with mesenchymal stem cells (MSCs) injected into contralatera

228 onitor the in vitro differentiation of human mesenchymal stem cells (MSCs) into osteoblasts.

229 nd thus facilitated migration of bone marrow mesenchymal stem cells (MSCs) into the fusion materials.

230 Mesenchymal stem cells (MSCs) loaded with oncolytic viru

231 cells activates RAGE and CXCR4 expression on mesenchymal stem cells (MSCs) located in tumor stroma.

232 EVs) secreted from human bone marrow-derived mesenchymal stem cells (MSCs) on SE-induced adverse chan

233 Mesenchymal stem cells (MSCs) possess immunoregulatory,

234 Therapeutic factors secreted by mesenchymal stem cells (MSCs) promote angiogenesis in vi

235 Extracellular vesicles derived from mesenchymal stem cells (MSCs) represent a novel approach

236 Mesenchymal stem cells (MSCs) represent promising resour

237 Here, we show that pregnancy mobilizes mesenchymal stem cells (MSCs) to the circulation and tha

238 Cell fusion can occur between mesenchymal stem cells (MSCs) transplanted to improve ca

239 The microcarriers were seeded with mesenchymal stem cells (MSCs) using a dynamic culture te

240 ds that can effectively localize and engraft mesenchymal stem cells (MSCs) with high disease-site fid

241 cular evidence has connected tissue-specific mesenchymal stem cells (MSCs) with mesenchymal transit a

242 blood cells (RBCs), platelets, neutrophils, mesenchymal stem cells (MSCs), and bacteria have been ut

243 s, primarily based on using chondrocytes and mesenchymal stem cells (MSCs), are emerging as effective

244 Mesenchymal stem cells (MSCs), are excellent candidates

245 Herein, mesenchymal stem cells (MSCs), endothelial progenitor ce

246 e arsenal of bioactive molecules secreted by mesenchymal stem cells (MSCs), known as the secretome, h

247 Pericytes are widely believed to function as mesenchymal stem cells (MSCs), multipotent tissue-reside

248 (CS) based hydrogels were developed to host mesenchymal stem cells (MSCs), since their paracrine act

249 made these adult cells, collectively called mesenchymal stem cells (MSCs), strong candidates for fie

250 t Mycobacterium tuberculosis was taken up by mesenchymal stem cells (MSCs), where it established dorm

251 yeloma cells inhibit osteoblastogenesis from mesenchymal stem cells (MSCs), which can also differenti

252 a gene expression profile closely resembling mesenchymal stem cells (MSCs).

253 oduction of alpha-ketoglutarate (aKG) within mesenchymal stem cells (MSCs).

254 ll (iEC) spheroids, and the supporting human mesenchymal stem cells (MSCs).

255 exogenously seeded human bone marrow-derived mesenchymal stem cells (MSCs).

256 vascular endothelial cells (BMECs) and human mesenchymal stem cells (MSCs).

257 ate a transgenic approach to magnetize human mesenchymal stem cells (MSCs).

258 etinoids in the osteogenesis of human marrow mesenchymal stem cells (MSCs).

259 lated during chondrogenic differentiation of mesenchymal stem cells (MSCs).

260 direct the fate determination of multipotent mesenchymal stem cells (MSCs).

261 oncolytic herpes simplex virus (oHSV)-armed mesenchymal stem cells (MSCs).

262 ze thermal and mechanical signals applied to mesenchymal stem cells (MSCs).

263 r spheroids (MDA-MB-231 breast tumor cells + mesenchymal stem cells (MSCs)/human lung fibroblasts (HL

264 idative stress increased Ki-67 expression of mesenchymal stem cells (MSCs); cytostatic stress-resulte

265 Transplantation of mesenchymal stem cells/multipotent stromal cells (MSCs)

266 rthermore, IL-3 enhances RANKL expression in mesenchymal stem cells of wild-type mice but not in STAT

267 Human embryonic kidney (HEK) cells and ovine mesenchymal stem cells (oMSCs) were printed at tissue-re

268 ive childhood cancer likely originating from mesenchymal stem cells or osteo-chondrogenic progenitors

269 d with any serious adverse events related to mesenchymal stem cells or plug placement.

270 ort that specific ablation of Tsc1 using the mesenchymal stem cell-osteoblast lineage markers induced

271 ells, and comparison of periodontal ligament mesenchymal stem cells (PDLMSCs) and gingival mesenchyma

272 Periodontal ligament mesenchymal stem cells (PDLMSCs) are responsible for reg

273 termine whether periodontal ligament-derived mesenchymal stem cells (PDLSCs) have the ability to modu

274 d tumor cell proliferation but did not alter mesenchymal stem cell proliferation or osteoblast minera

275 animal due to the presence of epithelial and mesenchymal stem cells-provides a model for the study of

276 ivate multiple signaling pathways related to mesenchymal stem cell recruitment and bone regeneration.

277 te (HCCS-PDA) were examined by culturing rat mesenchymal stem cells (rMSCs) on HCCS-PDA and HCCS coat

278 iphyseal chondrocytes, marrow adipocytes and mesenchymal stem cell rosettes.

279 ds (1) acellular porcine pericardium and (2) mesenchymal stem cell-seeded acellular porcine pericardi

280 ived stem cells (ASCs) are a potential adult mesenchymal stem cell source for restoring endothelial f

281 se substitutions differentially impede human mesenchymal stem cell spreading and integrin alpha(2)-in

282 at network plasticity independently controls mesenchymal stem cell spreading through a biphasic relat

283 The mechanoresponse of human mesenchymal stem cells to e-beam patterned substrates wa

284 oblasts and adipose- and bone marrow-derived mesenchymal stem cells to obtain cancer-associated fibro

285 own about the molecular events that initiate mesenchymal stem cells to proliferate and differentiate

286 gs do not support the use of intramyocardial mesenchymal stem cells to promote cardiac recovery as me

287 drial dysfunction and impairs the ability of mesenchymal stem cells to promote distal lung epithelial

288 ting ER+ breast cancer cells and bone marrow mesenchymal stem cells to represent DTCs in a bone marro

289 l implant treatment starts with diffusion of mesenchymal stem cells to the wounded region and their s

290 mimetic scaffolds, seeded with human induced mesenchymal stem cells, to recapitulate the osseointegra

291 itive method was developed to evaluate human mesenchymal stem cells trans-differentiation to endothel

292 Mesenchymal stem cell treatment led to a significant inc

293 RATIONALE: Umbilical cord-derived mesenchymal stem cells (UC-MSC) are easily accessible an

294 Using umbilical cord-derived mesenchymal stem cells (uMSC) from offspring born to nor

295 n=15) or 100 million (n=15) allogeneic human mesenchymal stem cells via transendocardial injection (0

296 differentiation of human bone marrow-derived mesenchymal stem cells was assessed.

297 be expressed on proliferative endothelia and mesenchymal stem cells, was diminished in high passage C

298 Furthermore, mesenchymal stem cells were isolated and cultured from 2

299 tumor origin cells, and potentially BECs and mesenchymal stem cells, which give rise to Kaposi sarcom

300 ravitreal injection of adipose Myh11-derived mesenchymal stem cells, with ensuing myofibroblast diffe